Dr. Xiangbo Meng currently serves as a Professor in the School of Pharmaceutical Sciences at Peking University. He graduated from the School of Pharmacy of Peking University Medical College in 1997, and he received his Ph.D. in Medicinal Chemistry from the School of Pharmacy of Peking University in 2002. He started working at Shanghai WuXi AppTec Pharmaceutical Development Co., Ltd in 2002, and then in 2003, he went to the research group of Professor Pierre Sinay of the Department of Chemistry of Ecole Normale Supérieure in Paris for postdoctoral research. His research interests mainly include anti-tumor drugs; synthesis, asymmetric synthesis using sugar as a chiral source; asymmetric synthesis using sugar as a chiral auxiliary group, and research on anti-tumor drugs.
Dr. Xiangbo Meng currently serves as a Professor in the School of Pharmaceutical Sciences at Peking University. He graduated from the School of Pharmacy of Peking University Medical College in 1997, and he received his Ph.D. in Medicinal Chemistry from the School of Pharmacy of Peking University in 2002. He started working at Shanghai WuXi AppTec Pharmaceutical Development Co., Ltd in 2002, and then in 2003, he went to the research group of Professor Pierre Sinay of the Department of Chemistry of Ecole Normale Supérieure in Paris for postdoctoral research. His research interests mainly include anti-tumor drugs; synthesis, asymmetric synthesis using sugar as a chiral source; asymmetric synthesis using sugar as a chiral auxiliary group, and research on anti-tumor drugs.